Here you will find further links on the subject of sepsis. We also share some links to our partners or projects.
The Deutsche Sepsis-Gesellschaft is a German medical society with the objective to educate and sharpen the understanding of the clinical disease sepsis, both in the public and in the medical professional world. Guidelines for the prevention, diagnosis, therapy and the clinical follow up were and will be published on a regular basis.
In addition, the DSG organizes an international congress every two years - the Weimar Sepsis Update. Furthermore, the “Deutsche Sepsis-Hilfe” was founded to help patients and their families.
The Deutsche Sepsis-Hilfe e.V. is the world's first person affected initiative, in which patients and patient relatives come together. The affected persons can find information, assistance and helpful contacts here.
The Surviving Sepsis Campaign (SSC) is a global initiative to connect professional organizations with the goal of reducing mortality from sepsis. The purpose of the SSC is to create an international collaborative effort to improve the treatment of sepsis and to reduce the high mortality rate associated with the condition.
The SSC is also available as an app. It provides users with a screening tool to help identify patients with sepsis, allows to set up bundle alerts and provides easy access to the guidelines or the website.
The European Group on Immunology of Sepsis (EGIS) is a multidisciplinary group consisting of basic scientists, immunologists, infectious diseases and intensive care medicine specialists with a shared primary research interest in sepsis immunology. Our overarching goal is to develop and foster collaborative research by working in partnership with groups with similar interests, Medical and Scientific Societies, Academia and the Industry. Sepsis was recently redefined by the SEPSIS-3 task force as a life-threatening organ dysfunction caused by a dysregulated host response to infection.
The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems and combines life sciences and engineering. The IZI develops, optimizes and validates methods, materials and products for segments like Cell and Gene Therapy, Drugs and Diagnostics. The main areas of competence are cell biology, immunology, drug biochemistry, bioanalytics and bioproduction as well as process development and automation. The research activities are focusing on the areas of immunoncology and infection research.
CEOS stands for Center of Extracorporeal Organ Support. The network of competence has been founded by the University of Rostock in 2008. The objective is to combine scientific and industrial know how and experience in order to bundle resources in the research of possible extracorporeal therapeutic approaches for the regeneration in organ failure.
The section of nephrology at the University Hospital Rostock researches i.a. at extension and optimization of the clinical application of dialysis and blood purification procedures for various indications such as kidney diseases and kidney transplantation, liver failure or septic shock.
The most important research topics include initial clinical applications of innovative adsorbers, ongoing developments of albumin dialysis procedures and diagnostics based on the albumin binding capacity.
A major part of the research is carried out as part of research dialysis and within the Fraunhofer Project Group Extracorporeal Immunomodulation (EXIM), which is affiliated to the Fraunhofer Institute for Cell Therapy and Immunology (IZI) in Leipzig. The laboratories and offices of these groups are located on the campus in the BMFZ in Rostock, Germany.
The BMFZ is one of the most modern installations of its kind. Today, it is already well known beyond borders, also due to the support of the European Union, the Federal Republic of Germany, the State of Mecklenburg West Pomerania, Rostock city and the University of Rostock.
With the establishment of the Biomedical Research Center, science, business and politics are taking a joint initiative to promote and develop the economic region in the medium and long term.
The idea of concept is "economy and science next door". The goal of the BMFZ is to offer state-of-the-art research and production opportunities to start-ups - from university's research to biomedicine and biotechnology. The results of their scientific work will be integrated into the research of application and are developed and marketed on site.